Imricor Financial Statements From 2010 to 2024

Stocks . Australia . 
Stock . Imricor Medical Systems
IMR Stock   1.16  0.06  5.45%   
Imricor Medical financial statements provide useful quarterly and yearly information to potential Imricor Medical Systems investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Imricor Medical financial statements helps investors assess Imricor Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Imricor Medical's valuation are summarized below:
Gross Profit
-1.5 M
Market Capitalization
313.4 M
Enterprise Value Revenue
277.7954
Revenue
824.3 K
Earnings Share
(0.17)
There are currently eighty-three fundamental trends for Imricor Medical Systems that can be evaluated and compared over time across competitors. All traders should confirm Imricor Medical's regular fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Imricor Medical Total Revenue

608,180

Check Imricor Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Imricor Medical's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 59.9 K or Depreciation And Amortization of 525.5 K, as well as many indicators such as . Imricor financial statements analysis is a perfect complement when working with Imricor Medical Valuation or Volatility modules.
  
This module can also supplement various Imricor Medical Technical models . Check out the analysis of Imricor Medical Correlation against competitors.

Imricor Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets15.9 M8.3 M10.1 M
Slightly volatile
Short and Long Term Debt Total10.9 M10.4 M3.9 M
Slightly volatile
Other Current Liabilities4.1 M3.9 M735.3 K
Slightly volatile
Total Current Liabilities7 M6.7 M2 M
Slightly volatile
Other Liabilities459 K483.2 K2 M
Slightly volatile
Property Plant And Equipment Net2.9 M4.6 M1.7 M
Slightly volatile
Current Deferred Revenue881.5 K854 K634.9 K
Slightly volatile
Accounts Payable2.2 M2.1 M536.6 K
Slightly volatile
Cash789.9 K831.5 K6.1 M
Slightly volatile
Non Current Assets Total3.7 M6.4 M2.2 M
Slightly volatile
Non Currrent Assets Other1.6 M1.5 M430.3 K
Slightly volatile
Cash And Short Term Investments789.9 K831.5 K6.1 M
Slightly volatile
Common Stock Shares Outstanding128.8 M156.6 M109.5 M
Slightly volatile
Long Term Debt Total2 M2 M2.1 M
Very volatile
Liabilities And Stockholders Equity15.9 M8.3 M10.1 M
Slightly volatile
Non Current Liabilities Total19.2 M18.3 M6.9 M
Slightly volatile
Capital Surpluse59.6 M112.1 M43.3 M
Slightly volatile
Other Current Assets2.7 M2.6 M851.7 K
Slightly volatile
Other Stockholder Equity183.7 M175 M56.9 M
Slightly volatile
Total Liabilities17.9 M17.1 M7.8 M
Slightly volatile
Total Current Assets5.5 M5.8 M7.8 M
Slightly volatile
Short Term Debt376.4 K667.9 K213.3 K
Slightly volatile
Common Stock23.5 K24.8 K24.9 M
Slightly volatile
Property Plant Equipment2.6 M4.1 M1.6 M
Slightly volatile
Common Stock Total Equity88.3 M122 M80 M
Slightly volatile
Capital Lease Obligations1.4 M1.4 M2.1 M
Slightly volatile
Net Invested Capital216.5 K227.9 K16.8 M
Slightly volatile
Property Plant And Equipment Gross5.5 M6.4 M4 M
Slightly volatile
Capital Stock86.7 M103.8 M62.5 M
Slightly volatile
Non Current Liabilities Other1.4 M795 K2.1 M
Slightly volatile
Intangible Assets435.7 K340.2 K601.5 K
Slightly volatile
Long Term Investments97.7 K109.9 K119.7 K
Slightly volatile
Short and Long Term Debt291.8 K328.3 K357.5 K
Slightly volatile

Imricor Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income59.9 K63 K136.4 K
Pretty Stable
Depreciation And Amortization525.5 K707.5 K348.9 K
Slightly volatile
Interest Expense45.5 K47.9 K216.6 K
Pretty Stable
Selling General Administrative3.9 M5.1 M2.8 M
Slightly volatile
Total Revenue608.2 K615.6 K727.6 K
Very volatile
Other Operating Expenses15.7 M26.3 M11.1 M
Slightly volatile
Research Development6.6 M7.9 M5.2 M
Slightly volatile
Selling And Marketing Expenses2.3 M2.7 M1.2 M
Slightly volatile
Reconciled Depreciation636.8 K707.5 K389.8 K
Slightly volatile

Imricor Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow9.1 M5.7 M6.9 M
Slightly volatile
Depreciation1.4 M1.3 M446.2 K
Slightly volatile
Other Non Cash Items6 M10.4 M3.5 M
Slightly volatile
Capital Expenditures78.6 K82.8 K186.5 K
Slightly volatile
Total Cash From Financing Activities11.1 M8.2 M7 M
Slightly volatile
End Period Cash Flow789.9 K831.5 K5.4 M
Pretty Stable
Change To Netincome1.3 M1.2 M801.3 K
Slightly volatile
Issuance Of Capital Stock10.1 M5.8 M9.2 M
Pretty Stable

Imricor Fundamental Market Drivers

Cash And Short Term Investments831.5 K

About Imricor Medical Financial Statements

Imricor Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Imricor Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Imricor Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Imricor Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue854 K881.5 K
Total Revenue615.6 K608.2 K
Cost Of Revenue2.6 M1.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Imricor Stock Analysis

When running Imricor Medical's price analysis, check to measure Imricor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imricor Medical is operating at the current time. Most of Imricor Medical's value examination focuses on studying past and present price action to predict the probability of Imricor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imricor Medical's price. Additionally, you may evaluate how the addition of Imricor Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY